PRNewsWire
04 Jul 2026, 02:00 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
ADMA Biologics is facing a class action securities lawsuit alleging the use of channel stuffing to artificially inflate revenue. — Allegations of revenue manipulation (channel stuffing) strike at the core of financial integrity and usually lead to significant valuation corrections.
-0.80The lawsuit alleges that ADMA Biologics failed to disclose material information regarding related party transactions and lacked adequate internal controls. — Poor internal controls and undisclosed related-party deals suggest systemic governance failures and potential further financial irregularities.
-0.60The class action seeks to recover losses for investors who purchased ADMA securities between August 9, 2024, and March 25, 2026. — Defines the scope of potential legal liability and the specific window of financial exposure for the company.
-0.30Which stocks this story touches
Continue reading
6 related stories
Top 3 movers · tap to explore
The company is facing a class action securities lawsuit alleging corporate fraud, channel stuffing, and internal control failures.
The company is mentioned as being subject to a class action lawsuit notice.
The company is mentioned as being subject to a class action lawsuit notice.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Business Wire
4h ago
